UNLV Emergency Medicine Residency
  • Home
  • About Us
    • Curriculae
    • Orientation
    • Salary & Benefits
    • Training Sites
    • Resident Life
    • Family Life
  • Who We Are
    • Faculty
    • Residents >
      • PGY1
      • PGY2
      • PGY3
    • PEM Fellows
    • Alumni
  • What We Do
    • Events Medicine
    • Tactical Medicine
    • Wilderness Medicine
    • EMS
    • Ski Patrol
    • Ultrasound
  • Students
    • Residency Applicants
    • Military Applicants
    • Diversity & Inclusion
    • URM Second Look
  • PEM Fellowship
    • PEM Fellows
    • PEM Faculty
    • Fellowship Nuts and Bolts
    • Pediatric Pearls
  • Research
    • Resident Research
    • Recent Research & Publications
    • Research Assistant Program
  • VegasFOAM

pem pearl: Group a strep pharyngitis 

There has been a lot of discussion recently about the treatment of GAS in children. Here are the present evidence-based indications for treatment for strep pharyngitis:
1. Antibiotic treatment for any child 3 years of age and older with symptomatic pharyngitis or tonsillopharyngitis or scarlatiniform rash who have a positive microbiologic test for GAS (NAAT, rapid antigen test, or culture).
2. Antibiotic treatment for ALL children suspected to have acute rheumatic fever or post-streptococcal glomerulonephritis.
3. Antibiotic treatment for ALL children with acute rheumatic fever and a household contact with GAS.
4. Antibiotic treatment for children less than 3 years of age with prolonged nasal discharge, tender anterior cervical lymphadenopathy, and low-grade fever especially with a household contact with GAS.
5. Antibiotic treatment for pre-pubertal children with the acute onset of obsessive-compulsive disorder.
6. Antibiotic treatment for all children less than 3 years of age who are symptomatic and who have a positive microbiologic test for GAS (NAAT, rapid antigen test, or culture) with a household GAS contact.
Recommended treatment for strep pharyngitis:
1. Amoxicillin 50 mg/Kg/day PO (maximum 1000 mg per day) once daily or BID for 10 days
2. If penicillin IgE-mediated hypersensitivity reaction—azithromycin 12 mg/Kg/day (maximum 500 mg/dose) PO once daily for 5 days.
3. If penicillin and cephalosporins can not be used and macrolide resistance is a concern— clindamycin 7 mg/Kg/dose (maximum 300 mg/dose) PO TID for 10 days.
PROS for treatment of GAS:
1. The reason that acute rheumatic fever (ARF) cases are so low is because we are treating strep pharyngitis. If we stop the number of cases will rise.
2. ARF is not the only complication of GAS. Many hospitals have seen an increase in severe streptococcal infections including intracranial complications, and these children can have long-term complications.
3. If we are not going to treat GAS, why order the test?
4. From a medicolegal standpoint if a child has a positive strep test and is not treated and has a complication it will be hard to defend in the legal system.
CONS for treatment of GAS:
1. The incidence of ARF is very low in resource rich areas. Our country qualifies as resource rich.
2. The incidence of GAS in infants is very low.
3. Treating GAS for every positive test contributes to antibiotic resistance.
In my research most pediatric infectious disease experts recommend treatment per the recommendations. Some tips from them:
1. If you feel the child has a viral illness do not do a GAS test.
2. Use the Centor criteria in children over 3 years of age with less than 3 days of acute pharyngitis symptoms.
3. Use amoxicillin for treatment of GAS for antibiotic stewardship unless there is a contraindication.
4. Treat infants who test positive for GAS, are symptomatic, and have a household member with GAS.

CONTACT US


​901 Rancho Lane, Ste 135
Las Vegas, NV 89106

P: (702) 383-7885
F: (702) 366-8545
Picture

ABOUT US

Curriculae
Orientation
Salary & Benefits
Training Sites
Resident Life
PEM Fellowship

WHO WE ARE

Faculty
Residents
Alumni

WHAT WE DO

Events Medicine
Tactical Medicine
Wilderness Medicine
EMS
Ski Patrol
Ultrasound

STUDENTS

Clerkship
Residency Applicants
Military Applicants
Diversity & Inclusion

RESEARCH

Recent Research & Publications
​Research Assistant Program

FOAM BLOG

VegasFOAM
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
LasVegasEMR.com is neither owned nor operated by the Kirk Kerkorian School or Medicine at UNLV . It is financed and managed independently by a group of emergency physicians. This website is not supported financially, technically, or otherwise by UNLVSOM nor by any other governmental entity. The affiliation with Kirk Kekorian School of Medicine at UNLV logo does not imply endorsement or approval of the content contained on these pages.

​
Icons made by Pixel perfect from www.flaticon.com
  • Home
  • About Us
    • Curriculae
    • Orientation
    • Salary & Benefits
    • Training Sites
    • Resident Life
    • Family Life
  • Who We Are
    • Faculty
    • Residents >
      • PGY1
      • PGY2
      • PGY3
    • PEM Fellows
    • Alumni
  • What We Do
    • Events Medicine
    • Tactical Medicine
    • Wilderness Medicine
    • EMS
    • Ski Patrol
    • Ultrasound
  • Students
    • Residency Applicants
    • Military Applicants
    • Diversity & Inclusion
    • URM Second Look
  • PEM Fellowship
    • PEM Fellows
    • PEM Faculty
    • Fellowship Nuts and Bolts
    • Pediatric Pearls
  • Research
    • Resident Research
    • Recent Research & Publications
    • Research Assistant Program
  • VegasFOAM